Home > Services > Clinical Research Studies > Clinical Trials Details
<< Back to Results
An Open-Label, Multicenter Study with an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension when Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to less than 12 years) with Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic-Clonic Seizures.
For more information about a financial conflict of interest (FCOI) or to review the Essentia Health FCOI policy, click here.
Last Updated: 05/08/2017